SAN DIEGO, Oct. 31, 2017 /PRNewswire/ -- Synthetic Genomics, Inc. announced today that the company has entered into a collaboration with Ceva Santé Animale to utilize Synthetic Genomics' next ...

The aim of the Center for Synthetic Genomics is to spark new developments in synthetic genomics through basic research and technology development using methods of artificial intelligence.

SAN DIEGO, June 1, 2017 /PRNewswire/ -- Synthetic Genomics, Inc. and Advaxis, Inc. (NASDAQ:ADXS) announced today that they have completed development and deployment of the first current good ...

Investors interested in the Genomics and Synthetic Biology theme should consider these stocks: Twist Bioscience Corporation, Wave Life Sciences, and CRISPR Therapeutics AG.

Yesterday BNET's Kirsten Korosec covered a new $600 million deal by ExxonMobil to develop biofuels using algae, an uncharacteristic move for a company that has often scoffed at renewable energy ...

Start-up Synthetic Genomics launched in June, and wants to create new forms of life. The idea is far enough “out there” for Steve Jurvetson, partner at Silicon Valley venture firm, Draper ...

Key innovation: Created synthetic bacterial cells, possibly paving the way for organisms specifically tailored to make fuels. Technology: Strains of algae engineered by Synthetic Genomics excrete ...

The future of fuel is green, slimy, and reeks of fish. "Fish smell like fish because fish eat algae," says Imad Ajjawi, a geneticist at the synbio company Synthetic Genomics in La Jolla, CA that ...

Whether synthetic biology will follow the historic path of uneven distribution that has beset many new technologies is contingent on the outcome of these two debates.

3 Genomics Stocks and Synthetic Biology Stocks in Spotlight Twist Biosciences has developed a disruptive DNA synthesis platform to industrialize the engineering of biology that provides DNA for a ...